Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2000
08/03/2000WO2000044347A1 Medicated stick composition
08/03/2000WO2000044346A1 Lowering skin temperature
08/03/2000WO2000044342A1 Galenic formulation containing biotin
08/03/2000WO2000044333A2 Novel injectable antimalarial compositions of artemisinin
08/03/2000WO2000037062A3 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
08/03/2000WO2000030605A3 Method for producing medicaments from plant extracts, in a solid form of administration
08/03/2000WO2000027999A3 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000025824A3 Stable preparations with hyperforin
08/03/2000WO2000024896A3 Biological material for preparing pharmaceutical compositions for treating mammals
08/03/2000WO2000023065A3 Storable active substance concentrate with formoterol
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000009675A9 Adenovirus formulations for gene therapy
08/03/2000WO1999059638A8 Compositions and methods for the delivery of nucleic acid molecules
08/03/2000DE19903241A1 Galenische Formulierung Drug formulation
08/03/2000DE19852928C1 Strukturen in Form von Hohlkugeln Structures in the form of hollow spheres
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361268A1 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000CA2361262A1 Buccal delivery system for proteinaceous medicaments
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2359994A1 Production of tetravalent antibodies
08/02/2000EP1023908A2 Medical composition of hydroxy acid-based oligomer
08/02/2000EP1023904A2 Adjuvants for use in vaccines
08/02/2000EP1023899A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
08/02/2000EP1023896A2 Opioid formulations for treating pain
08/02/2000EP1023895A2 Base for suppository
08/02/2000EP1023842A2 Edible powder material having excellent shelf stability
08/02/2000EP1023440A1 Enteric coated microgranules for stabilizing lactic acid bacteria
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023251A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
08/02/2000EP1023084A1 Compositions for controlling bacterial colonization
08/02/2000EP1023083A1 Veterinary vaccines
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023077A1 Opthalmic composition
08/02/2000EP1023075A1 Liquid presentations of oxazaphosphorine-containing pharmaceutical products
08/02/2000EP1023072A1 Analgesic compositions
08/02/2000EP1023069A1 Nicotine compositions and methods of formulation thereof
08/02/2000EP1023055A1 Inhibition of crystallization in transdermal devices
08/02/2000EP1023053A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption
08/02/2000EP1023052A2 Medicament excipient particles for tissue-specific application of a medicament
08/02/2000EP1023051A1 Oral morphine multiparticulate formulation
08/02/2000EP1023049A1 Preparation of a directly mouldable tabletting auxiliary
08/02/2000EP1023047A1 Particles
08/02/2000EP1023039A2 Use of alkylmonoglucosides as molecular vectors
08/02/2000EP0758889B1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
08/02/2000EP0682528B1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
08/02/2000EP0613373B1 Risedronate delayed-release compositions
08/02/2000CN1261806A Polyethylene glycol-interferon alpha conjugates for therapy of infection
08/02/2000CN1261805A Polylactic acid scleral plugs
08/02/2000CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions
08/02/2000CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein
08/02/2000CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
08/02/2000CN1261797A Self-emulsifying formulation forlipophilic compounds
08/02/2000CN1261796A Self-emulsifying formulation for lipophilic compounds
08/02/2000CN1261794A Solubilized sertraline compositions
08/02/2000CN1261791A Targeted liposomal constructs for diagnostic and therapeutic uses
08/02/2000CN1261790A Self-emulsifying formulation for lipophilic compounds
08/01/2000US6096911 Purifying ethoxylated fatty acids for the production of pharmaceutical formulations by treatment with a solid substance comprising a mixture of aluminum oxide and a silicate
08/01/2000US6096834 Hydrolyzable delivery system using crosslinked polymeric resins as vehicles
08/01/2000US6096728 Composition and method for treating inflammatory diseases
08/01/2000US6096727 Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide
08/01/2000US6096726 Multicomponent complex for use with substrate
08/01/2000US6096709 Use of angiotensin II fragments and analogs thereof in tissue repair
08/01/2000US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor
08/01/2000US6096340 Omeprazole formulation
08/01/2000US6096338 Delivery systems for hydrophobic drugs
08/01/2000US6096336 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
08/01/2000US6096335 Stable particulate complexes having a lamellar, rolled, and condensed structure
08/01/2000US6096332 Low temperature
08/01/2000US6096331 Methods and compositions useful for administration of chemotherapeutic agents
08/01/2000US6096329 Synergistic mixture containing fipronil
08/01/2000US6096326 Skin care compositions and use
08/01/2000US6096289 Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
08/01/2000CA2183881C Pharmaceutical excipient having improved compressibility
08/01/2000CA2183746C Oral vehicle compositions
08/01/2000CA2149150C Injectable taxol composition with improved stability
08/01/2000CA2140887C New nimesulide salt cyclodextrine inclusion complexes
08/01/2000CA2117265C Enhanced skin penetration system for improved topical delivery of drugs
08/01/2000CA2064861C Injectable slow-release galenical
08/01/2000CA2024651C High-absorbable transvaginal preparation containing biologically active polypeptide
08/01/2000CA2004038C Sustained release compositions using as matrix hemicellulose extracted from wheat bran
07/2000
07/29/2000CA2297367A1 Base for suppository
07/29/2000CA2290078A1 Erysipelothrix rhusiopathiae antigens and vaccine compositions
07/28/2000CA2293008A1 Premixed alatrofloxacin injectable compositions
07/27/2000WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043043A1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery
07/27/2000WO2000043042A1 Parenteral metolazone formulations
07/27/2000WO2000043041A1 Medicinal compositions with improved oral absorption
07/27/2000WO2000043034A2 Monodisperse hexameric acylated insulin analog formulations
07/27/2000WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt
07/27/2000WO2000042998A1 Multiparticulate bisoprolol formulation
07/27/2000WO2000042997A1 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds
07/27/2000WO2000042992A2 Compositions and methods for mucosal delivery
07/27/2000WO2000042990A1 Liposome formulations
07/27/2000WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/27/2000WO2000042988A1 Method of identifying and treating inflamed tissue
07/27/2000WO2000042987A2 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
07/27/2000WO2000042975A1 Preparation for dental treatment
07/27/2000WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same
1 ... 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 ... 1712